Skip to search formSkip to main contentSkip to account menu

Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A phase II study of neoadjuvant FOLFOX4 and cetuximab (C) in patients with locally advanced rectal adenocarcinoma (RA).
e14122 Background: For resectable RA, 5-fluorouracil (5FU) with radiotherapy (RT) has been used commonly in the neoadjuvant… 
2009
2009
Six of the Best, Upper GI 16
Introduction: The benefits of neoadjuvant therapy in the treatment of patients with resectable oesophageal carcinoma are… 
2008
2008
Phase II study of first-line treatment in metastatic colorectal cancer (MCRC) with GONO-FOLFOXIRI (Irinotecan, Oxaliplatin and Infusional 5FU/LV) plus Bevacizumab
2008
2008
First-line treatment of metastatic colorectal cancer (MCRC) with folfoxiri (irinotecan, oxaliplatin and infusional 5FU/LV) in combination with bevacizumab (BV): A phase II study by the G.O.N.O. Group
2008
2008
Phase II study of irinotecan, oxaliplatin and infusional 5FU/LV (GONO-FOLFOXIRI) plus bevacizumab (BV) as first-line treatment in metastatic colorectal cancer (MCRC)
2003
2003
A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin
PurposeSince preclinical studies have shown more than additive cytotoxicity and DNA damage with the combination of gemcitabine… 
2003
2003
German Trial Demonstrates Minor Benefits of Infusional 5FU‐LV Regimen over Mayo Clinic Regimen
2003
2003
Chemotherapy with Irinothecan, 5-Fluorouracil and Folinic Acid in the First-Line Management of Advanced Colorectal Carcinoma: Retrospective Study
Colorectal cancer is one of the most common adult malignant tumors, affecting one person in twenty in the United States and in…